Skip to main content

Table 2 Laboratory evaluations of the patients

From: Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China

 

Mean

±SD

Normal range

Ferritin (ng/ml)

2002

1161

22–322

Liver function

 ALT (IU/L)

34.3

36.8

0–40

 AST (IU/L)

37.3

19.9

0–40

 TBIL (μmol/L)

21

10.9

0.9–17.1

 TP (g/L)

64.3

4.47

46–80

 ALB (g/L)

40.1

2.03

35–55

Bone metabolism

 25(OH)D3 (ng/ml)

28.3

10.9

30–100

 Ca (mmol/L)

2.15

0.3

2.2–2.7

 P (mmol/L)

1.57

0.16

0.96–2.1

 PTH (pmol/L)

3.61

2.24

1.3–6.8

Kidney function

 Cr (μmol/L)

26

6.21

21–65

 Bun (mmol/L)

3.9

1.29

1.5–7

Thyroid function

 T3 (nmol/L)

2

0.31

1.1–3.9

 T4 (nmol/L)

100

24

45.3–223.9

 TSH (μIU/L)

3

1.8

0.64–6.27

  1. Sera from patients with β-thalassemia major (β-TM) were subjected to various biomarker evaluations in the medical diagnostic lab at Shenzhen Children’s Hospital (SZCH). The serum biomarker concentrations of patients with β-TM were compared to the corresponding normal ranges according to the laboratory standards at SZCH